daunorubicin
Showing 1 - 25 of 85
Acute Myeloid Leukemia Trial in Suzhou (Venetoclax Oral Tablet, Daunorubicin)
Recruiting
- Acute Myeloid Leukemia
- Venetoclax Oral Tablet
- Daunorubicin
-
Suzhou, Jiangsu, China
- +1 more
Jul 3, 2023
Leukemia, Acute Myeloid Leukemia, AML Trial in Tampa (Selinexor, Daunorubicin, Cytarabine)
Completed
- Leukemia
- +2 more
- Selinexor
- +2 more
-
Tampa, FloridaH. Lee Moffitt Cancer Center and Research Institute
Sep 30, 2022
Relapsed Pediatric ALL, Relapsed Pediatric AML, Refractory Acute Myeloid Leukemia Trial in Kansas City (Daunorubicin)
Recruiting
- Relapsed Pediatric ALL
- +3 more
- Daunorubicin
-
Kansas City, MissouriChildren's Mercy Hospital
Jul 1, 2022
Acute Myeloid Leukemia Trial in Baltimore, New York, Chapel Hill (Alvocidib, Cytarabine, Daunorubicin)
Acute Lymphocytic Leukemia, Acute Myeloid Leukemia Trial in Fairway (Daunorubicin)
Completed
- Acute Lymphocytic Leukemia
- Acute Myeloid Leukemia
- Daunorubicin
-
Fairway, KansasUniversity of Kansas Cancer Center - Clinical Research Center
Jan 12, 2022
Acute Myeloid Leukemia, MDS Trial in Bronx (Venetoclax Oral Tablet, Daunorubicin, Cytarabine)
Recruiting
- Acute Myeloid Leukemia
- Myelodysplastic Syndromes
- Venetoclax Oral Tablet
- +2 more
-
Bronx, New YorkMontefiore Einstein Cancer Center
Jul 14, 2022
Acute Promyelocytic Leukemia, Induction Therapy, Oral Trial in Beijing (Etoposide, Daunorubicin)
Recruiting
- Acute Promyelocytic Leukemia
- +2 more
- Etoposide
- Daunorubicin
-
Beijing, Beijing, ChinaPeking University Institute of Hematology
Apr 26, 2023
Acute Myeloid Leukemia With KMT2A Rearrangement, Acute Myeloid Leukemia With NPM1 Mutation Trial (Biospecimen Collection, Bone
Not yet recruiting
- Acute Myeloid Leukemia With KMT2A Rearrangement
- Acute Myeloid Leukemia With NPM1 Mutation
- Biospecimen Collection
- +7 more
- (no location specified)
Jun 1, 2023
Acute Myeloid Leukemia, Mixed Lineage Acute Leukemia, Mixed Lineage Leukemia Gene Mutation Trial (Ziftomenib, Venetoclax,
Not yet recruiting
- Acute Myeloid Leukemia
- +10 more
- Ziftomenib
- +4 more
- (no location specified)
Feb 17, 2023
Acute Lymphoid Leukemia, Minimal Residual Disease, Gene Abnormality Trial in São Paulo (Prednisone, Vincristin, Daunorubicin)
Recruiting
- Acute Lymphoid Leukemia
- +3 more
- Prednisone
- +9 more
-
São Paulo, SP, BrazilInstituto do Cancer do Estado de Sao Paulo
Jul 24, 2023
Relapsed or Refractory Acute Myeloid Leukemia Trial in Taiyuan (Selinexor, Homoharringtonine, Daunorubicin)
Recruiting
- Relapsed or Refractory Acute Myeloid Leukemia
- Selinexor
- +5 more
-
Taiyuan, Shanxi, ChinaTao Wang
Feb 9, 2023
Philadelphia Chromosome-Negative Acute Lymphoblastic Leukemia Trial in Tianjin (Vincristine, Daunorubicin, Cyclophosphamide)
Recruiting
- Philadelphia Chromosome-Negative Acute Lymphoblastic Leukemia
- Vincristine
- +9 more
-
Tianjin, ChinaInstitute of Hematology & Blood Diseases Hospital
Dec 13, 2022
Acute Myeloid Leukemia Trial in Baltimore, Houston (Atovaquone, Cytarabine, Daunorubicin)
Active, not recruiting
- Acute Myeloid Leukemia
- Atovaquone
- +4 more
-
Baltimore, Maryland
- +1 more
Oct 7, 2022
Acute,Leukemia, Lymphoid Trial in Tianjin (Dasatinib, prednisone, cyclophosphamide)
Completed
- Acute,Leukemia, Lymphoid
- Dasatinib
- +12 more
-
Tianjin, Tianjin, ChinaInstitute of Hematology & Blood Diseases Hospital
Aug 2, 2022
Adult Acute Lymphocytic Leukemia Trial in Frankfurt (Cyclophosphamide, Dexamethasone, Vincristine)
Completed
- Adult Acute Lymphocytic Leukemia
- Cyclophosphamide
- +20 more
-
Frankfurt, GermanyUniversity of Frankfurt, Medical Dept. II
Aug 17, 2022
Acute Myeloid Leukemia Trial in Tokyo (Quizartinib, Cytarabine, Idarubicin)
B-cell Acute Lymphoblastic Leukemia Trial in United States (Inotuzumab ozogamicin, Prednisone Pill, Daunorubicin)
Recruiting
- B-cell Acute Lymphoblastic Leukemia
- Inotuzumab ozogamicin
- +6 more
-
Nashville, Tennessee
- +3 more
Aug 14, 2022
Lymphoblastic Lymphoma Trial in San Diego, Memphis (Prednisone, Vincristine, Daunorubicin)
Down Syndrome, Acute Lymphoblastic Leukemia, Childhood Cancer Trial in Worldwide (Daunorubicin, Prednisolone, Vincristine)
Recruiting
- Down Syndrome
- +2 more
- Daunorubicin
- +9 more
-
Shatin, New Territories, Hong Kong
- +9 more
Sep 26, 2022
Acute Myeloid Leukemia Trial in United States (Gilteritinib, Midostaurin, Daunorubicin)
Active, not recruiting
- Acute Myeloid Leukemia
- Gilteritinib
- +3 more
-
Scottsdale, Arizona
- +43 more
Nov 17, 2022
Acute Myeloid Leukemia Trial in Japan (PF-04449913, Low dose ARA-C (LDAC), Daunorubicin)
Active, not recruiting
- Acute Myeloid Leukemia
- PF-04449913
- +5 more
-
Nagoya, Aichi, Japan
- +8 more
Jan 12, 2022
Acute Myeloid Leukemia Trial in Boston (MLN9708, Cytarabine, Daunorubicin)
Recruiting
- Acute Myeloid Leukemia
- MLN9708
- +2 more
-
Boston, MassachusettsMassachusetts General Hospital
Jan 18, 2021